{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T06:52:35Z","timestamp":1765608755806,"version":"3.37.3"},"reference-count":45,"publisher":"Royal College of General Practitioners","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BJGP Open"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In 2017, approximately 73% of antibiotics in England were prescribed from primary care practices. It has been estimated that 9%\u201323% of antibiotic prescriptions between 2013 and 2015 were inappropriate. Reducing antibiotic prescribing in primary care was included as one of the national priorities in a financial incentive scheme in 2015\u20132016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To investigate whether the effects of the Quality Premium (QP), which provided performance-related financial incentives to clinical commissioning groups (CCGs), could be explained by practice characteristics that contribute to variations in antibiotic prescribing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design &amp; setting<\/jats:title><jats:p>Longitudinal monthly prescribing data were analysed for 6251 primary care practices in England from April 2014 to March 2016.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>Linear generalised estimating equations models were fitted, examining the effect of the 2015\u20132016 QP on the number of antibiotic items per specific therapeutic group age\u2013sex related prescribing unit (STAR-PU) prescribed, adjusting for seasonality and months since implementation. Consistency of effects after further adjustment for variations in practice characteristics were also examined, including practice workforce, comorbidities prevalence, prescribing rates of non-antibiotic drugs, and deprivation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Antibiotics prescribed in primary care practices in England reduced by -0.172 items per STAR-PU (95% confidence interval [CI] = -0.180 to -0.171) after 2015\u20132016 QP implementation, with slight increases in the months following April 2015 (+0.014 items per STAR-PU; 95% CI = +0.013 to +0.014). Adjusting the model for practice characteristics, the immediate and month-on-month effects following implementation remained consistent, with slight attenuation in immediate reduction from -0.172 to -0.166 items per STAR-PU. In subgroup analysis, the QP effect was significantly greater among the top 20% prescribing practices (interaction <jats:italic>p<\/jats:italic>&lt;0.001). Practices with low workforce and those with higher diabetes prevalence had greater reductions in prescribing following 2015\u20132016 QP compared with other practices (interaction <jats:italic>p<\/jats:italic>&lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In high-prescribing practices, those with low workforce and high diabetes prevalence had more reduction following the QP compared with other practices, highlighting the need for targeted support of these practices and appropriate resourcing of primary care.<\/jats:p><\/jats:sec>","DOI":"10.3399\/bjgpopen20x101052","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T04:49:38Z","timestamp":1594788578000},"page":"bjgpopen20X101052","source":"Crossref","is-referenced-by-count":9,"title":["Investigating the mechanism of impact and differential effect of the Quality Premium scheme on antibiotic prescribing in England: a longitudinal study"],"prefix":"10.3399","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2104-7062","authenticated-orcid":false,"given":"Philip Emeka","family":"Anyanwu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"Pouwels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeem","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2645-6191","authenticated-orcid":false,"given":"Benedict W J","family":"Hayhoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Tonkin-Crine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Borek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monsey","family":"Mcleod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9ire","family":"Costelloe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1987","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"2020120311350810000_4.3.bjgpopen20X101052.1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks245"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.1403"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.3","unstructured":"O\u2019Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations. 2 Jul 2020. https:\/\/amr-review.org\/sites\/default\/files\/160518_Final%20paper_with%20cover.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.4","unstructured":"Public Health England (2018) English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report 2018 (PHE, London)."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx500"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.6","unstructured":"National Institute for Health and Care Excellence (2008) Respiratory tract infections (self-limiting): prescribing antibiotics. 2 Jul 2020. https:\/\/www.nice.org.uk\/guidance\/cg69\/resources\/respiratory-tract-infections-selflimiting-prescribing-antibiotics-pdf-975576354757."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022979"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2018.12.003"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.9","unstructured":"NHS England (2015) Quality Premium: 2015\/16 Guidance for CCGs. 2 Jul 2020. https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2013\/12\/qual-prem-guid.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.10","unstructured":"National Institute for Clinical Excellence (2015) Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use. 2 Jul 2020. https:\/\/www.nice.org.uk\/guidance\/ng15\/resources\/antimicrobial-stewardship-systems-and-processes-for-effective-antimicrobial-medicine-use-pdf-1837273110469."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy902"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.12","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky237"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.13","unstructured":"Public Health England (2017) English surveillance programme for antimicrobial utilisation and resistance (ESPAUR): report 2017 (PHE, London)."},{"issue":"543","key":"2020120311350810000_4.3.bjgpopen20X101052.14","first-page":"785","article-title":"Containing antibiotic resistance: decreased antibiotic-resistant coliform urinary tract infections with reduction in antibiotic prescribing by general practices","volume":"57","author":"Butler","year":"2007","journal-title":"Br J Gen Pract"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.15","unstructured":"Care Quality Commission (2018) The safer management of controlled drugs: annual update 2017. 2 Jul 2020. https:\/\/www.cqc.org.uk\/sites\/default\/files\/20180718_controlleddrugs2017_report.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.16","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp18X700457"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx501"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.18","unstructured":"NHS Digital (2019) Patients registered at a GP practice. 2 Jul 2020. https:\/\/digital.nhs.uk\/data-and-information\/data-tools-and-services\/data-services\/general-practice-data-hub\/patients-registered-at-a-gp-practice."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.19","unstructured":"NHS Digital (2018) Workforce. 2 Jul 2020. https:\/\/digital.nhs.uk\/data-and-information\/areas-of-interest\/workforce."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.20","unstructured":"Department for Communities and Local Government (2016) The English indices of deprivation 2015 \u2014 frequently asked questions (FAQs). 2 Jul 2020. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/579151\/English_Indices_of_Deprivation_2015_-_Frequently_Asked_Questions_Dec_2016.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.21","doi-asserted-by":"publisher","DOI":"10.1068\/a37168"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.22","unstructured":"NHS Digital (2018) Quality and Outcomes Framework, achievement, prevalence and exceptions data \u2014 2017\u201318 [PAS]. 2 Jul 2020. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/quality-and-outcomes-framework-achievement-prevalence-and-exceptions-data\/2017-18."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.23","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00055705"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.24","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmm023"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1016"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.26","unstructured":"NHS Business Services Authority (2018) Information Services Portal. Detailed Prescribing Information. 9 Jul 2020. https:\/\/digital.nhs.uk\/data-and-information\/areas-of-interest\/prescribing\/practice-level-prescribing-in-england-a-summary."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.27","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl188"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.28","doi-asserted-by":"crossref","unstructured":"Hardin JW Hilbe JM (2002) Generalized Estimating Equations (Chapman and Hall\/CRC, Boca Raton, FL).","DOI":"10.1201\/9781420035285"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.29","unstructured":"Diabetes UK (2019) Tackling the crisis: transforming diabetes care for a better future. England. 2 Jul 2020. https:\/\/www.diabetes.org.uk\/resources-s3\/2019-04\/Diabetes%20UK%20Tackling%20the%20Crisis.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.30","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00379-4"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.31","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181f4e499"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.32","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx115"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-030093"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.34","doi-asserted-by":"crossref","unstructured":"Royal College of General Practitioners (2012) TARGET antibiotics toolkit. 2 Jul 2020. https:\/\/www.rcgp.org.uk\/clinical-and-research\/resources\/toolkits\/amr\/target-antibiotics-toolkit.aspx.","DOI":"10.1093\/jacamr\/dlaa021"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.35","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv492"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.36","unstructured":"Public Health England (2016) Antimicrobial resistance resource handbook. 2 Jul 2020. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/768999\/PHE_AMR_resource_handbook.pdf."},{"key":"2020120311350810000_4.3.bjgpopen20X101052.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00215-4"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.38","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.0702"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa0807651"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2006.00707.x"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-2171.2009.00090.x"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.42","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9020044"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa1801495"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.44","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.8040"},{"key":"2020120311350810000_4.3.bjgpopen20X101052.45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l6463"}],"container-title":["BJGP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3399\/bjgpopen20X101052","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:44:22Z","timestamp":1607024662000},"score":1,"resource":{"primary":{"URL":"http:\/\/bjgpopen.org\/lookup\/doi\/10.3399\/bjgpopen20X101052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,8,25]]},"published-print":{"date-parts":[[2020,8]]}},"alternative-id":["10.3399\/bjgpopen20X101052"],"URL":"https:\/\/doi.org\/10.3399\/bjgpopen20x101052","relation":{},"ISSN":["2398-3795"],"issn-type":[{"type":"electronic","value":"2398-3795"}],"subject":[],"published":{"date-parts":[[2020,7,14]]}}}